FDA Inspection 660401 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007507466

The FDA completed an inspection of Octapharma Plasma, Inc. on May 6, 2010 in Des Moines, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 6, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Des Moines, IA (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
6321 CFR 606.65Safe, sanitary, orderly storage
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs